Welcome to LookChem.com Sign In|Join Free

CAS

  • or

140382-35-0

Post Buying Request

140382-35-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

140382-35-0 Usage

Description

2-Benzofurancarboxaldehyde, 5-fluorois an organic compound characterized by the presence of a benzofuran ring with a carboxaldehyde group at the 2nd position and a fluorine atom at the 5th position. This unique molecular structure endows it with specific chemical properties and reactivity, making it a valuable building block in the synthesis of various complex organic molecules.

Uses

Used in Pharmaceutical Industry:
2-Benzofurancarboxaldehyde, 5-fluorois used as a key intermediate in the synthesis of chiral benzofuryl β-nitro alcohols, which are important for the development of pharmaceutical compounds. The catalytic asymmetric Henry reaction allows for the selective formation of these chiral molecules, which are crucial in the design of drugs with improved efficacy and reduced side effects.
Used in Chemical Synthesis:
In the field of chemical synthesis, 2-Benzofurancarboxaldehyde, 5-fluoroserves as a versatile building block for the creation of a wide range of organic compounds. Its unique structure and reactivity make it a valuable component in the synthesis of various molecules with potential applications in different industries, such as agrochemicals, materials science, and specialty chemicals.

Check Digit Verification of cas no

The CAS Registry Mumber 140382-35-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,0,3,8 and 2 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 140382-35:
(8*1)+(7*4)+(6*0)+(5*3)+(4*8)+(3*2)+(2*3)+(1*5)=100
100 % 10 = 0
So 140382-35-0 is a valid CAS Registry Number.

140382-35-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-fluorobenzofuran-2-carbaldehyde

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:140382-35-0 SDS

140382-35-0Relevant articles and documents

PYRROLIDINE COMPOUNDS FOR THE TREATMENT OF MALARIA

-

, (2020/06/19)

Pyrrolidine derivatives of formula I are used as anti-malaria agents, wherein the variables are as defined herein. Method of employing such agents in the treatment and prevention of malaria are also provided herein.

Efficient synthesis of chiral benzofuryl β-amino alcohols via a catalytic asymmetric Henry reaction

Chen, Wei,Zhou, Zhao-Hui,Chen, Hong-Bin

, p. 1530 - 1536 (2017/02/15)

Chiral β-amino alcohol ligands were found effective for the copper(ii)-catalyzed asymmetric Henry reaction of benzofuran-2-carbaldehydes with nitromethane, which led to the formation of (S)-enriched benzofuryl β-nitro alcohols with satisfactory enantioselectivities (up to 98% ee). Using this catalytic protocol, bioactive (S)-benzofuryl β-amino alcohols could be conveniently prepared in short steps.

TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS

-

Page/Page column 40-41, (2010/11/17)

The invention relates to novel compounds for use in the treatment or prophylaxis of cancers and other proliferative conditions that are for example characterized by cells that express cytochrome P450 1B1 (CYP1B1) and allelic variants thereof. The invention also provides pharmaceutical compositions comprising one or more such compounds for use in medical therapy, for example in the treatment of prophylaxis of cancers or other proliferative conditions, as well as methods for treating cancers or other conditions in human or non-human animal patients. The invention also provides methods for identifying novel compounds for use in the treatment of prophylaxis of cancers and other proliferative conditions that are for example characterized by cells that express CYP1 B1 and allelic variants thereof. The invention also provides a method for determining the efficacy of a compound of the invention in treating cancer.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 140382-35-0